Studies have demonstrated that the amplification/overexpression of vascular endothelial growth factor (VEGF 1,2,4) and platelet-derived growth factor receptor-α (PDGFRα) are present in SCLC [69,72]. The gene discussed is VEGFA; the disease is small cell lung carcinoma.